Last reviewed · How we verify
NCT05006053
i-Minds Professional Stakeholders Qualitative Study
trial testing Interviews/Focus groups in Child Sexual Abuse, Confirmed, Sequela in 26 participants. Completed in 31 January 2022.
31 January 2022
Quick facts
| Lead sponsor | Sandra Bucci |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 26 |
| Start date | 1 September 2021 |
| Primary completion | 31 January 2022 |
| Estimated completion | 31 January 2022 |
| Sites | 4 locations across United Kingdom |
Drugs / interventions tested
- Interviews/Focus groups
Conditions studied
- Child Sexual Abuse, Confirmed, Sequela — all drugs for Child Sexual Abuse, Confirmed, Sequela →
Sponsor
Sandra Bucci
Who can join
18 and older, any sex, with Child Sexual Abuse, Confirmed, Sequela. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main aim of this study is to understand healthcare professionals' perceptions, as well as the barriers and enablers (and unintended consequences), relevant to the uptake of the digital intervention and its future integration into existing NHS infrastructure. We will use a qualitative study design and utilise semi-structured interviews and focus groups to gather the views and opinions from up to 30 healthcare professionals who work with young people to provide mental health and / or sexual assault care across two sites: Greater Manchester, UK and Edinburgh, Scotland.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
The experiences of practitioners working with young people exposed to online sexual abuse.
Quayle E, Schwannauer M, Varese F, Cartwright K, et al · · 2023 · cited 15× · PMID 36993927 · DOI 10.3389/fpsyt.2023.1089888 -
What are practitioners' views of how digital health interventions may play a role in online child sexual abuse service delivery?
Quayle E, Schwannauer M, Varese F, Cartwright K, et al · · 2024 · cited 6× · PMID 38572144 · DOI 10.3389/fdgth.2024.1325385 -
A digital intervention to improve mental health and interpersonal resilience in young people who have experienced technology-assisted sexual abuse: a feasibility clinical trial.
Bucci S, Varese F, Quayle E, Cartwright K, et al · · 2026 · PMID 41493931 · DOI 10.1111/camh.70060 -
A digital intervention to improve mental health and interpersonal resilience in young people who have experienced Technology-Assisted Sexual Abuse: a feasibility clinical trial
Bucci S, Varese F, Quayle E, Cartwright K, et al · · 2025 · DOI 10.1101/2025.06.27.25330408
Verify or expand the search:
- PubMed search for NCT05006053
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05006053 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sandra Bucci
- Last refreshed: 22 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05006053.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing